Purchase Order 75N95018P00674
- Not listed
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $91,545.00 firm fixed-price purchase order is for the delivery of assorted cell consumables. The contract has no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, has...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Purchase Order worth $106,172.66 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract has a completion date of February 28, 2019 and does not utilize any set-asides. As a division of Thermo Fisher Scientific, Life Technologies has delivered genetic analyzers, reagents, assays, instruments,...
- The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
- This is a federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $4,453.78 firm fixed-price contract is for the delivery of products and services to support the agency's biomedical research, applied markets, and forensic analysis initiatives. As a division...
- This firm fixed-price purchase order contract was awarded by the National Institute of Child Health and Human Development, a civilian agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for $99,048.38. The contract does not have a set-aside designation. Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, is providing products and services to support biomedical research, applied markets, and forensic analysis for...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The $12,407.97 firm fixed-price purchase order is for "LABORATORY START-UP REGENTS FOR THE LCSMS" and has an ultimate completion date of October 28, 2020. The contract is not set aside for any specific business type. Life...
- This is a $142,497.17 firm fixed-price purchase order awarded to Life Technologies Corporation by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services. The contract supports the delivery of scientific instruments, reagents, and consumables to enable biomedical research, applied markets, and forensic analysis for the federal government. Life Technologies serves as a prime contractor across multiple agencies, including the National...
- This $57,000 firm-fixed-price purchase order was awarded to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The award is not associated with a set-aside program. Life Technologies Corporation, as the prime contractor, will provide the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), with specialized biotechnology products, genetic analysis technologies, and...
- This firm-fixed-price purchase order was awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, by the National Institutes of Health (NIH) Clinical Center. The $363,228.02 contract is to provide the NIH with various scientific instruments, reagents, and consumables to support biomedical research, applied markets, and forensic analysis. The contract is not set aside. Life Technologies has served as a prime contractor across multiple federal agencies and has also...
- This federal contract award to Life Technologies Corporation, a division of Thermo Fisher Scientific, is for the provision of "DRUGS AND BIOLOGICALS" with a ceiling value of $14,320.00. The contract was awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), and has an ultimate completion date of September 21, 2012. The contract is a Firm Fixed Price Purchase Order and does not utilize any set-aside...
This is a $80,568 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Life Technologies Corporation, a division of Thermo Fisher Scientific, to conduct testing of compounds against a panel of kinase assays. The contract was awarded in response to a full and open competition under simplified acquisition procedures, with no set-aside designation. The work supports the translational research initiatives of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) by evaluating compounds for their effects on kinase activity, which can inform drug discovery efforts. Life Technologies, as the prime contractor, will provide the necessary services, personnel, equipment, and facilities to perform the testing as described in the statement of work. This contract award is associated with the company's broader federal contracting capabilities, including multiple active indefinite delivery vehicles with NIH, the Department of the Interior, and the Department of Veterans Affairs to support their specialized research and healthcare missions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Determining Kinases Inhibited by Malaria Compounds | NIHDA201800525 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 9/4/18, 3:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | $0 | 7/12/23 | |
| P00002 | Funding Only Action | ($226) | 1/9/23 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 2/23/22 | |
| Not listed | Not listed | $80.8k | 9/14/18 |